Futures Up, Dell Fl...
Health Care: Health Services
Response Genetics Inc. (RGDX: NASDAQ)
$1.43 -0.02 | -1.38%
05/17/13 - 03:59 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 1.43 |
| 52 Week High | 2.05 |
| 52 Week Low | 0.70 |
| Avg. Daily Vol. (Mil) | 0.03 |
| Beta (3 year) | 0.74 |
| Share Related Items | |
| Mkt Cap (Mil) | 46.90 |
| Shares Out (Mil) | 32.80 |
| Float (Mil) | 13.45 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.10 |
| Current Ratio | 3.30 |
| LT Debt/ Equity | 0.21 |
| Total Debt / Equity | 0.24 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 2.30 |
| Price/Book | 9.36 |
| Price/Cash Flow | -4.30 |
| Per Share Data | |
| Earnings | -0.19 |
| Sales | 0.62 |
| Book Value | 0.15 |
| Cash Flow | -0.33 |
| Business Summary | |
|---|---|
| Response Genetics, Inc. is a life sciences company, engaged in the research and development of innovative clinical diagnostic tests for cancer based on its proprietary technologies. | |
| General Information | |
| 1640 Marengo Street
6th Floor Los Angeles, CA 90033 |
|
| www.responsegenetics.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 90 | |
| CEO: Mr. Thomas A. Bologna | |
| Short Interest | |
| Current Month (Mil) | 0.01 |
| Previous Month (Mil) | 0.01 |
| Short Interest Ratio (Days) | 1.40 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -71.10 |
| Return on Investments | -186.00 |
| Profitability | |
| Gross Margin | 52.20 |
| EBIT Margin | -26.40 |
| Profit Margin | -55.50 |
Portfolios with RGDX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks With Big Insider Buy...
- Userjaysan Portfolio 1
- Usercurry Portfolio 1
- Usercharlesl950 Portfolio 1
- UserWACKJDDUDE Portfolio 1
Latest RGDX Headlines from TheStreet
- Response Genetics, Inc. Announces Contract With Blue Shield Of California 05.16.13 | 07:05 am
- Response Genetics, Inc. Announces First Quarter 2013 Financial Results 05.14.13 | 07:05 am
- Response Genetics To Present At The 2013 UBS Global Healthcare Conference 05.08.13 | 07:05 am
- Response Genetics, Inc. To Release First Quarter 2013 Financial Results And Host Conference Call On May 14, 2013 05.06.13 | 07:05 am
- Response Genetics, Inc. Announces Fourth Quarter And Year-End 2012 Financial Results 03.21.13 | 07:03 am
- Response Genetics To Present At The 25th Annual ROTH Conference 03.12.13 | 07:03 am
- Response Genetics, Inc. To Release Fourth Quarter And Year-End 2012 Financial Results And Host Conference Call On March 21, 2013 03.07.13 | 07:03 am
- 5 Under-$10 Stocks Setting Up to Trade Higher 11.30.12 | 12:11 pm
- 5 Stocks With Big Insider Buying 09.19.12 | 12:09 pm
- Insiders Trading ODP RGDX EGL BRKR 09.18.12 | 01:09 pm
Press Releases for RGDX
- Response Genetics, Inc. To Offer Enhanced ALK Testing Program For Metastatic Lung Cancer Patients - Business Wire 06.28.12 | 08:06 am
- Response Genetics Announces Presentation Of Lung Cancer Study Results At 2012 American Society Of Clinical Oncology Annual Meeting - Business Wire 05.30.12 | 08:05 am
- Response Genetics, Inc. Announces First Quarter Financial Results - Business Wire 05.10.12 | 08:05 am
- Response Genetics, Inc. To Release First Quarter Financial Results And Host Conference Call On May 10, 2012 - Business Wire 05.04.12 | 08:05 am
- Response Genetics, Inc. Announces Year-End And Fourth Quarter Financial Results - Business Wire 03.27.12 | 08:03 am
- Response Genetics, Inc. Announces Appointment Of Stephanie Astrow, Ph.D., As Vice President, Research And Development - Business Wire 03.26.12 | 08:03 am
- Response Genetics, Inc. To Release Fourth Quarter And Full-Year 2011 Financial Results And Host Conference Call On March 27, 2012 - Business Wire 03.21.12 | 08:03 am
- Response Genetics Regains NASDAQ Compliance - Business Wire 02.21.12 | 07:02 am
- Response Genetics To Present At The 22nd Annual UBS Global Healthcare Services Conference - Business Wire 02.06.12 | 07:02 am
- Response Genetics Raises More Than $7.8 Million In Financing - Business Wire 02.02.12 | 07:02 am
Partner Headlines for RGDX
- Benzinga's Small Cap Movers for Friday November 30, 2012 - Benzinga 12.02.12 | 11:12 am
- Glaxo Increases Stake in RGDX - Analyst Blog - NASDAQ 09.18.12 | 09:09 pm
- Response Genetics: This Train Is About To Leave The Station - Seeking Alpha 02.16.12 | 09:02 am
- Response Genetics Stock Soars 31% On $7.8M Offering News - Seeking Alpha 02.03.12 | 08:02 am
- Biomarker Diagnostics Drive Personalized Medicine but Path to Market Still Rife With Hurdles - Seeking Alpha 07.07.10 | 07:07 am
- Three Promising Small-Cap Cancer Plays - Seeking Alpha 05.17.10 | 08:05 am
- Response Genetics: An Earnings Primer - Seeking Alpha 05.12.10 | 06:05 am
- UPDATE 1-Response Genetics inks deal with Glaxo, shares soar - Reuters 05.11.10 | 10:05 am
